Company Overview and News
June marks the eighth month I have officially tracked the taxable account's dividend income. The total amount of dividend income received was $676.96.
SOJA ETP.PRC GIS XOM IDCC EPR.PRG O.PRF SKT LTC OPRF BPL SEP COP MIC CINF AAPL CAH EMR BBT SO TLP WLK O MSB OZRK CMI ETP SPG.PRJ HP ORI SPG WPC ADM
Multiple economic players and observers are singing the same song: the US economy is acting well despite Federal Reserve rates hikes.
PANW MS.PRE RCL MS.PRF FDX NFLX CCL MS.PRG PCAR MS.PRA CMI V MS.PRI BK MS.PRK CASS AAPL CCL CELG MS ED IVZ
39 of 91 Dividend Achievers (10 or more years of higher dividends) were tagged "safer" because they showed positive annual returns, and free cash flow yields greater than dividend yields 7/11/18.
HEP WHG O.PRF O OPRF CMI VZA NNN.PRD NNN.PRF NNN.PRE ORI CVX LAZ VZ WELL WPC QCOM NHI LEG NNN IVZ
The first half of 2018 is already over, so it is time to look back at how our portfolio performed, the purchases we made and to check our income growth.
SOJA LMT GIS XOM O.PRF TWX OPRF CVS ABT NKE HON AAPL ABBV DIS ABT VTR HON SO GILD O MA TWC RB CMI TGT V AFL PEP JNJ CVX DG MSFT SBUX ABBV QCOM
Cummins Inc. (CMI - Free Report) has announced that its board approved an increase in its quarterly cash dividend on common stock to $1.14 per share. The revised dividend will be paid on Sep 4 to shareholders of record as of Aug 22, 2018.
FOXF VC CMQMY MGA MG CMI
Stocks continue to get more expensive despite the trade war headwinds investors face in the weeks ahead. S&P 500 stocks currently trade at 24 times trailing earnings and 17 times forward earnings making the selection of new additions to a portfolio that much more difficult.
WDC GS.PRB MS.PRE GS.PRA MS.PRF MS.PRG CVS MS.PRA NRGEO NWL GS GLSSP AMZN CAH MS NEE JBK GSC GS.PRICL TFG NYTAB CMI GSJ NEE.PRI GS.PRJ NRG NEE.PRJ GS.PRI MS.PRI MU NEE.PRC GS.PRD MS.PRK GS.PRC NEE.PRQ NEE.PRR GJS GS.PRN GS.PRK
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning.
GNK GIS JWN CIT EDR DUKH AMC ENTG PDYPF INFY KORS MSFT OXY HELE LMT KKR TM KLIC WFC.PRL WFC.PRJ LB MPC BAC WFC.PRT ZION WFC.PRR WFC.PRQ WFC.PRP WFC.PRO WFC.PRN CCL KO WFC.PRY INTC WDFC WFC.PRX WFC.PRW WFC.PRV LUV NCLH DUK VRCA HMC OTC JPM ZUMZ TSLA ESPR TTM TOL HA RCL UAL KEY CATO CHRA ALGT VLKAY OSTK RNLSY BAC NJR OTEX FAST BKE CCL MDLZ HOG CMI PNC INFY AHBIF FOXA WFCNP RNSDF JBLU USX NEW WIMHY ALK GS MYL JEF GRKGF DAL DIS ABEV WFC WIMHF WFC.WS BUD C CMCSA COST BCNQY WMH SNY AVLR PEP SNE
I collected a personal record $865 of dividends in June and a total of $1933 in Q2.
WFCNP HD WFC.PRL WFC.PRJ PRU WFC.PRT WFC.PRR WFC.PRQ WFC.PRP SWK WFC.PRO WFC.PRN WFC.PRY WFC.PRX WFC.PRW WFC.PRV MO WFC PRU WFC.WS DUKH GLW PFK DUK UTX CMI MDT PEP JNJ PRH SBUX PJH
The week saw the release of the auto sales report for the month of June. U.S. auto sales jumped in the month, defying the odds of rising interest rates, higher gas prices and large supply of used vehicles. While the first half of the year saw auto sales rise 1.8%, sales in June increased 5% compared with a year ago. Strong consumer confidence and low level of unemployment boosted auto sales. There is however the lurking fear of this joyride being derailed due to President Trump’s proposed tariffs.
DTK HOG JMPLF CMI VLKAF GM.WS.A GM.WS.B ALV GM.WS.C JMPLY GM GM.WSB AAP VLKAY
Cummins Inc. (CMI - Free Report) is acquiring Efficient Drivetrains, Inc. (“EDI”), a company that engages in the designing and manufacturing of hybrid, and fully-electric power solutions for the commercial market. This acquisition will aid Cummins to be a global leader in electrified power. The deal is expected to complete by the third quarter on satisfying customary closing conditions.
VC CMQMY ABX MGA MG JMPLY ALSN JMPLF CMI ABX
24m - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
1h - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
22h - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
Silicon Investor Message Boards
This table lists all message boards related to CMI / Cummins, Inc. on message board site Silicon Investor.
as of ET